Literature DB >> 3032395

Angioinvasion in breast carcinoma. An immunohistochemical study of factor VIII-related antigen.

S A Martin, N Perez-Reyes, G Mendelsohn.   

Abstract

Histologic sections from 63 patients with infiltrating duct carcinoma of the breast were selected for study by immunohistochemical staining with antibody against human Factor VIII-related antigen. Of these 63, 30 had no lymph node metastases at the time of surgery, while 33 had axillary lymph node metastases. A positive correlation exists between the presence of vascular invasion and lymph node metastases. Sixty-nine percent of patients with lymph node metastases had vascular invasion while only 26% of patients without lymph node metastases showed evidence of invasion of blood vessels. The finding of vascular invasion by tumor in patients without axillary lymph node metastases at the time of mastectomy may explain the occurrence of disseminated disease years after treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032395     DOI: 10.1002/1097-0142(19870601)59:11<1918::aid-cncr2820591113>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.

Authors:  Rainer Kuefer; Kathleen C Day; Celina G Kleer; Michael S Sabel; Matthias D Hofer; Sooryanarayana Varambally; Christoph S Zorn; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

2.  Prognostic value of the immunocytochemical detection of extramural venous invasion in Dukes' C colorectal adenocarcinomas. A preliminary study.

Authors:  G Lapertosa; P Baracchini; E Fulcheri; R Tanzi
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  Nucleolar organiser regions: new prognostic variable in breast carcinomas.

Authors:  E Sivridis; B Sims
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

4.  Clinicopathologic features associated with long-term survival in node-negative breast cancer patients.

Authors:  T Kato; T Kimura; R Miyakawa; S Tanaka; T Kamio; K Yamamoto; K Hamano; M Aiba; M Kawakami
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

Authors:  G Viale; A Giobbie-Hurder; B A Gusterson; E Maiorano; M G Mastropasqua; A Sonzogni; E Mallon; M Colleoni; M Castiglione-Gertsch; M M Regan; K N Price; R W Brown; R Golouh; D Crivellari; P Karlsson; C Öhlschlegel; R D Gelber; A Goldhirsch; A S Coates
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

6.  Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer.

Authors:  T Kato; T Kimura; R Miyakawa; A Fujii; K Yamamoto; S Kameoka; T Nishikawa; T Kasajima
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

7.  Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.

Authors:  Fadia J A Gujam; James J Going; Zahra M A Mohammed; Clare Orange; Joanne Edwards; Donald C McMillan
Journal:  BMC Cancer       Date:  2014-09-18       Impact factor: 4.430

8.  The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer.

Authors:  T Kato; S Kameoka; T Kimura; T Nishikawa; M Kobayashi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.